Tina Ventura
Chief Investor Relations Officer
Replay available
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Q2 2026 earnings conference call, held 2026-07-30. Replay captured from the company's public earnings webcast.

Chief Investor Relations Officer
Chief Executive Officer
Chief Medical Officer
Chief Financial Officer
Analyst, Cantor Fitzgerald
Analyst, Barclays
Analyst
Analyst, TD Cohen
Watch the replay and follow the connected company analysis, news, and investor updates for Madrigal Pharmaceuticals, Inc..
WEBVTT 00:00:00.031 -- 00:00:02.072 Good morning, and thank you for standing by. 00:00:02.072 -- 00:00:07.253 Welcome to Magical Pharmaceuticals' second quarter 2026 earnings conference calls. 00:00:07.253 -- 00:00:10.054 At this time, all participants are in a listen-only mode. 00:00:10.054 -- 00:00:14.036 After the speaker's presentation, there will be a question and answer session. 00:00:14.036 -- 00:00:17.396 To ask a question during the session, 00:00:17.577 -- 00:00:20.158 you will have to press star 11 on your telephone. 00:00:20.158 -- 00:00:24.059 You will then hear an automated message advising that your hand is raised. 00:00:24.059 -- 00:00:27.490 To withdraw your question, please press star 11 again. 00:00:27.490 -- 00:00:31.031 Please be advised that today's conference call is being recorded. 00:00:31.031 -- 00:00:35.972 I would now like to introduce Ms. Tina Ventura, Chief Investor Relations Officer. 00:00:35.972 -- 00:00:38.612 Please go ahead. 00:00:39.332 -- 00:00:43.573 Good morning, everyone, and thank you for joining us to discuss Madrigal's second quarter 00:00:43.573 -- 00:00:48.654 2026 results. We issued a press release this morning and posted a slide deck 00:00:48.654 -- 00:00:54.595 to accompany this webcast on the Investor Relations section of our website. 00:00:54.607 -- 00:00:59.249 On the call with me today is Bill Sibold, Chief Executive Officer, Dave Soergel, Chief 00:00:59.249 -- 00:01:03.331 Medical Officer, and Mardi Dier, Chief Financial Officer. 00:01:03.331 -- 00:01:07.532 They will provide prepared remarks followed by Q&A. 00:01:07.613 -- 00:01:12.015 Please note on slide two, we will be making certain forward-looking statements today. 00:01:12.015 -- 00:01:17.177 We refer you to our SEC filings for a discussion of the risks tha...